Novartis
NOVN
Delayed Swiss Exchange - 12/13 05:31:34 pm
83.85CHF
+0.36%
Prev.83.5500
Open83.2500
High84.2500
Low82.8000
Volume5 197 029
Last news
Financials
Sales 2017 49 174 M
EBIT 2017 11 962 M
R. net 2017 7 465 M
Debt 2017 17 812 M
Rend. 2017 3,37%
P/E ratio 2017 24,47
P/E ratio 2018 21,32
EV / Sales 2017 4,85x
EV / Sales 2018 4,64x
Capitalization 220 B
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers surgical, ophthalmic...
Sector :
Pharmaceuticals - NEC
Calendar :
2017-12-12 Presentation
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance84,285,284,5
Spread/Res.-0,42%-1,5%-0,71%
Spread/Supp.2,7%6,4%8,1%
Support81,778,877,6